Coronary angiographic changes in patients with cardiac events in the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT)

Am J Cardiol. 2002 Oct 1;90(7):776-8. doi: 10.1016/s0002-9149(02)02611-5.

Authors

G B John Mancini¹, Bertram Pitt

Affiliation

¹ University of British Columbia, Vancouver, British Columbia, Canada. mancini@interchange.ubc.ca

PMID: 12356398
DOI: 10.1016/s0002-9149(02)02611-5

No abstract available

MeSH terms

Amlodipine / administration & dosage
Amlodipine / therapeutic use*
Calcium Channel Blockers / administration & dosage
Calcium Channel Blockers / therapeutic use*
Coronary Angiography
Coronary Artery Disease / diagnostic imaging
Coronary Artery Disease / drug therapy*
Coronary Artery Disease / pathology*
Disease Progression
Double-Blind Method
Female
Humans
Male
Multicenter Studies as Topic
Prospective Studies
Randomized Controlled Trials as Topic
Severity of Illness Index
Treatment Outcome

Substances

Calcium Channel Blockers
Amlodipine